PHARMHELP
ActiveFrom the official registers: KBO 3 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
PHARMHELP has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€82,956) and a net result of -€114,979. Equity has been shrinking by about 202% per year since 2023. Its solvency ranks better than 8% of 9,652 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Overview
Official details
KBO- Status
- Active since 27-06-2022 Normal situation
- Legal form
- Private limited company
- Registered office
- Rue d'Offignies 84, 7370 Dour
- Activity
- Other business support services NACE 82990and 1 other
- Establishment unit
- 2.332.872.566 7370 Dour, since 01-07-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 04-07-2022
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.8%
- Gross margin
- €364,467
- ▲ 43.3%
- Turnover
- ≈ €550,000
- estimated
- Loss
- €114,979
- Equity
- -€82,956
- Total assets
- €195,985
- ▲ 66.2%
- Staff
- 6.9 FTE
- ▲ 590%
Score breakdownraises riskCapped at 59: negative equityNegative equity -€82,956Loss of €114,979 (financial year 2025)lowers riskSector: Office administrative, office support and other business support activities (NACE 82)Size: total assets €195,985Show the evidence
Checked score
About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 82, micro). It does better than 5% of them on solvency, 37% on liquidity, 5% on profitability and 1% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
The company filed its last 3 accounts on average 7 days after the deadline. In the sector (NACE 82), the median for financial year 2024 was 7 days before the deadline, and 35% of those companies filed late.
Searched, nothing found (2)
Financials · financial year 2025, micro format
Annual accounts 2025
- Financial year ended
- 31-12-2025
- Filed on
- 22-07-2026
- Format
- micro format
- Reference
- 2026-00317538
2023 to 2025, 3 financial years
The operating result for 2025 is a loss of €110,346, after a profit of €27,341 in 2024. It is the lowest result since 2023.
Turnover is what the company sold, the result is what was left of it. A loss stands below the zero line.
Assets, equity and debt per financial year.
Above zero, the company can pay its short-term debts with what it holds in the short term.
The EBIT margin is the share of each euro of turnover left from operations. The return on assets is what the assets earn.
The higher the solvency, the better the company absorbs a setback.
A ratio above 1 means the short-term assets cover the short-term debts.
Average staff per financial year, in full-time equivalents (FTE).
Use the arrow keys on the chart for the figures per year.
The sector band is the middle half of the companies in Office administrative, office support and other business support activities (NACE 82). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30. The dashed line is the median. There is a sector band for net result, equity, total assets, working capital, solvency, current ratio, return on assets (ROA) and staff (FTE).
- 2025 Staff (FTE) +590% on 2024. The accounts now follow the micro format, last year the full format.
Companies with the same profile, two years later
Historical observationIn July 2024, 7,639 companies had the same profile as PHARMHELP has now. Two years later, 8.8% had gone bankrupt and 84.9% were still going.
- Micro
- 2 to 5 years old
- negative equity
- a loss of 10% of the balance sheet or more
Another 0.7% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of PHARMHELP itself is lower: 0.8% within 12 months. It rests on far more data about PHARMHELP than the profile alone.
Test of the method
The method was tested on the 497,445 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,639 companies, not a prediction for PHARMHELP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Remuneration, social security and pensions62 | €74,895 | €226,073 | €459,111 | ▲ 103% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | €217 | €902 | ▲ 316% |
| Other operating charges640/8 | €1,474 | €746 | €14,800 | ▲ 20× |
| Gross operating margin9900 | €89,379 | €254,377 | €364,467 | ▲ 43.3% |
| Operating profit (loss)9901 | €13,010 | €27,341 | -€110,346 | - |
| Financial income75/76B | €0 | €261 | €311 | ▲ 18.9% |
| Recurring financial income75 | €0 | €261 | €311 | ▲ 18.9% |
| Financial charges65/66B | €3,462 | €3,915 | €4,736 | ▲ 21.0% |
| Recurring financial charges65 | €3,462 | €3,915 | €4,736 | ▲ 21.0% |
| Profit (loss) for the period before taxes9903 | €9,548 | €23,687 | -€114,771 | - |
| Income taxes67/77 | €3,379 | €6,334 | €208 | ▼ 96.7% |
| Profit (loss) for the period9904 | €6,169 | €17,353 | -€114,979 | - |
| Profit (loss) for the period to be appropriated9905 | €6,169 | €17,353 | -€114,979 | - |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €36,870 | €117,896 | €195,985 | ▲ 66.2% |
| Fixed assets21/28 | €200 | €2,789 | €14,589 | ▲ 423% |
| Intangible fixed assets21 | - | - | €8,363 | - |
| Tangible fixed assets22/27 | - | €2,589 | €6,027 | ▲ 133% |
| Furniture and vehicles24 | - | €2,589 | €6,027 | ▲ 133% |
| Financial fixed assets28 | €200 | €200 | €200 | = |
| Current assets29/58 | €36,670 | €115,107 | €181,395 | ▲ 57.6% |
| Amounts receivable within one year40/41 | €12,504 | €45,725 | €62,697 | ▲ 37.1% |
| Trade receivables40 | €6,088 | €35,594 | €47,387 | ▲ 33.1% |
| Other amounts receivable41 | €6,416 | €10,132 | €15,310 | ▲ 51.1% |
| Current investments50/53 | - | €2,500 | €10,819 | ▲ 333% |
| Cash at bank and in hand54/58 | €21,797 | €53,844 | €78,900 | ▲ 46.5% |
| Deferred charges and accrued income490/1 | €2,369 | €13,038 | €28,980 | ▲ 122% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €36,870 | €117,896 | €195,985 | ▲ 66.2% |
| Equity10/15 | €6,169 | €22,023 | -€82,956 | - |
| Contributions10/11 | €5,000 | €8,500 | €18,500 | ▲ 118% |
| Profit (loss) carried forward14 | €1,169 | €13,523 | -€101,456 | - |
| Amounts payable17/49 | €30,700 | €95,874 | €278,941 | ▲ 191% |
| Amounts payable within one year42/48 | €24,973 | €95,874 | €240,258 | ▲ 151% |
| Trade debts44 | €4,500 | €15,667 | €148,121 | ▲ 845% |
| Suppliers440/4 | €337 | €15,667 | €148,121 | ▲ 845% |
| Bills of exchange payable441 | €4,164 | - | - | - |
| Taxes, remuneration and social security45 | €15,473 | €75,206 | €86,767 | ▲ 15.4% |
| Taxes450/3 | €6,979 | €26,422 | €14,440 | ▼ 45.3% |
| Remuneration and social security454/9 | €8,494 | €48,784 | €72,327 | ▲ 48.3% |
| Other amounts payable47/48 | €5,000 | €5,000 | €5,370 | ▲ 7.4% |
| Accrued charges and deferred income492/3 | €5,727 | - | €38,683 | - |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €6,169 | €17,353 | -€114,979 | - |
| + Depreciation and write-downs630 | - | €217 | €902 | ▲ 316% |
| Operating cash flow (approximation) | €6,169 | €17,570 | -€114,077 | - |
| Investment in fixed assets (approximation) | - | -€2,806 | -€12,702 | ▼ 353% |
| Change in cash | - | €32,047 | €25,056 | ▼ 21.8% |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Comparable companies
These companies have the same main activity as PHARMHELP: other business support services (NACE 82990). They are comparable in size and age: total assets between €142,000 and €244,000, founded between 2021 and 2023.
| Company | Founded | Total assets | Equity | Gross margin | Turnover | Net result | Financial year |
|---|---|---|---|---|---|---|---|
| PHARMHELP Dour | 2022 | €195,985 | -€82,956 | €364,467 | - | -€114,979 | 2025 |
| RLM service Oudergem | 2022 | €192,739 | €22,336 | €326,439 | - | -€5,496 | 2024 |
| MD SERVICES Mouscron | 2023 | €142,370 | €40,414 | €266,948 | €562,817 | €35,832 | 2025 |
| Virginal Business Center Ittre | 2022 | €229,278 | €37,509 | €289,190 | - | €4,841 | 2025 |
| HRIM Consulting Lennik | 2021 | €228,241 | €21,089 | €271,987 | - | €203,839 | 2025 |
| F2F COOP Antwerpen | 2023 | €180,970 | €87,193 | €374,900 | - | -€33,955 | 2025 |
| INDUSTRIAL AIR COMPANY BELGIUM Aarschot | 2022 | €243,569 | €8,721 | €240,249 | - | -€8,768 | 2025 |
They were chosen from the 9,746 other active companies with that main activity and annual accounts from the past two years. All companies with this main activity
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| LIENARD Amandine |
|
| TONDEUR Jeremy |
|
The board according to the articles of association
Board and representation
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alone
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Nommés avec ou sans limitation durée, un ou plusieurs administrateurs”
Audit, dissolution and liquidation
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “État actif et passif joint au rapport article 2:71.CSA, si plusieurs liquidateurs”
Articles of association, deed of 29-06-2022
Owners and capital
Capital transactions
- LIENARD Amandine sole founder · 100% at incorporation
- 29-06-2022 Incorporation · 100 shares
Shares according to the articles of association
Capital, shares and profit
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- One provision in the deed
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Tenus solliciter agrément selon mêmes formalités si ne deviennent pas plein droit actionnaires, cessions entre vifs, à titre onéreux ou…”
Other provisionsThese rules from the articles cover subjects other than the board, the shares, the purpose and the meetings.
Articles of association, deed of 29-06-2022 (in French)
Group and network
Connections & network
2 current directorsThe network starts from the directors of PHARMHELP. Every other company they run is a node.
History
Acts, filings and financial milestones
08-01
Gazette deed
Registered officeRegistered-office move2 points ▸
- General meeting, 30-12-2023
- Registered-office move, Rue d'Offignies 84 7370 Dour
29-06
Gazette deed
IncorporationAppointments: LIENARD Amandine (director) and TONDEUR Jeremy (director) · Founder · Founding capital7 points ▸
- Incorporation, 27-06-2022
- Founder, LIENARD Amandine
- Founding capital
- Other provision, “attestations autorisations ou licences selon règles administratives, autorisations préalables” (deed in French)
- Director appointment, LIENARD Amandine (director (not named in the articles))
- Director appointment, TONDEUR Jeremy (director (not named in the articles))
- Pre-incorporation commitments, “reprise d'engagements au nom de la société” (deed in French)
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Invoicing and payment
Financial year and general meeting
Accounts at the NBBThe scores and ratios are Checked's own calculations, not a credit decision.
Sites & property
1 establishment unit
Buildings and parcels at the address
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 53020D1312/00M000 | Wallonia | 141 m² | 1 · 80 m² | 9.3 m · 3 |